Septic shock due to Legionella pneumophila serogroup 2: usefulness of molecular biology for diagnosis, treatment and epidemiological investigation

Intensive Care Med. 2010 Aug;36(8):1439-40. doi: 10.1007/s00134-010-1859-8. Epub 2010 Mar 23.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Female
  • Humans
  • Legionella pneumophila / classification*
  • Legionnaires' Disease / complications*
  • Legionnaires' Disease / diagnosis*
  • Legionnaires' Disease / drug therapy
  • Legionnaires' Disease / physiopathology
  • Middle Aged
  • Molecular Biology*
  • Shock, Septic / microbiology*

Substances

  • Anti-Bacterial Agents